Skip to main content
SpringerLink
Log in

Neuropsychiatric Involvement in Systemic Lupus Erythematosus

  • Chapter
Book cover Nuclear Medicine in Psychiatry

Abstract

Neuropsychiatric manifestations have a strong impact on morbidity and mortality in systemic lupus erythematosus (SLE). CNS manifestations have been described in 18–67 % of cases. The diagnosis of cerebral involvement can be difficult and has to be differentiated from neurological complications which result from infection, uraemia, hypertension, drugs, or metabolic changes. The pathogenesis of numerous CNS manifestations remains unclear. Immune complex-mediated vasculitis or bland vasculopathy induced by antiphospholipid antibodies might result in infarction and consecutive neurological deficits. Diffuse Psychiatric Symptoms may be induced by autoantibodies and cytokines, which may interact with the neuronal network. In neuropsychiatric SLE, the diagnostic approach includes brain imaging, duplex sonography of carotid and vertebral arteries, echocardiography to exclude embolism from valve lesions, serological tests including antiphospholipid antibodies, and analysis of cerebrospinal fluid of the brain. The imaging method of choice to investigate brain anatomy is magnetic resonance imaging (MRI) with gadolinium contrast enhancement. While MRI scans are highly sensitive in detecting infarction, atrophy and white matter lesions, patients with Psychiatric manifestations frequently have normal MRI results. Thus, inconspicuous MRI findings do not exclude neuropsychiatric lupus. In these patients, nuclear medicine techniques such as single-photon emission computed tomography (SPECT) and positron emission tomography (PET) may be useful in detecting perfusion defects and alterations of metabolism in morphologically normal appearing brain regions. However, due to the lack of specificity and oversensitivity, the findings of functional imaging have to be interpreted with some caution. Future studies will show whether the combination of MRI, functional brain imaging, serological, cerebrospinal and neuropsychological tests can be more specific than Single diagnostic procedures.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 129.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 169.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 219.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  • Abel T, Gladman DD, Urowitz MB (1980) Neuropsychiatric lupus. J Rheumatol 7:325–333

    PubMed  CAS  Google Scholar 

  • Abu-Shakra M, Urowitz MB, Gladman DD, Gough J (1995) Mortality studies in systemic lupus erythematosus. Results from a Single center. I. Causes of death. J Rheumatol 22:1259–1264

    PubMed  CAS  Google Scholar 

  • Ainiala H, Hietaharju A, Loukkola J, Peltola J, Korpela M, Metsanoja R et al (2001a) Validity of the new American College of Rheumatology criteria for neuropsychiatric lupus Syndromes: a population-based evaluation. Arthritis Rheum 45:419–423

    Article  PubMed  CAS  Google Scholar 

  • Ainiala H, Loukkola J, Peltola, Korpela M, Hietaharju A (2001b) The prevalence of neuropsychiatric Syndromes in systemic lupus erythematosus. Neurology 57:496–500

    Article  PubMed  CAS  Google Scholar 

  • Alcocer-Varela J, Aleman-Hoey D, Alarcon-Segovia D (1992) Interleukin-1 and interleukin-6 activities are increased in the cerebrospinal fluid of patients with CNS lupus erythematosus and correlate with local late T-cell activation markers. Lupus 1:111–117

    Article  PubMed  CAS  Google Scholar 

  • American College of Rheumatology (1999) The American College of Rheumatology nomenclature and case definitions for neuropsychiatric lupus Syndromes. Arthritis Rheum 42:599–608

    Article  Google Scholar 

  • Asherson RA, Derksen RH, Harris EN, Bouma BN, Gharavi AE, Kater L et al (1987a) Chorea in systemic lupus erythematosus and “lupus-like” disease: association with antiphospholipid antibodies. Semin Arthritis Rheum 16:253–259

    Article  PubMed  CAS  Google Scholar 

  • Asherson RA, Mercey D, Phillips G, Sheehan N, Gharavi AE, Harris EN et al (1987b) Recurrent stroke and multi-infarct dementia in systemic lupus erythematosus: association with antiphospholipid antibodies. Ann Rheum Dis 46:605–611

    Article  PubMed  CAS  Google Scholar 

  • Asherson RA, Khamashta MA, Gil A, Vazquez JJ, Chan O, Baguley E et al (1989) Cerebrovascular disease and antiphospholipid antibodies in systemic lupus erythematosus, lupus-like disease, and the primary antiphospholipid Syndrome (see comments). Amer J Med 86:391–399

    Article  PubMed  CAS  Google Scholar 

  • Awada HH, Mamo HL, Luft AG, Ponsin JC, Kahn MF(1987) Cerebral blood flow in systemic lupus erythematosus with and without central nervous System involvement. J Neurol Neurosurg Psychiatry 50:1597–1601

    Article  PubMed  CAS  Google Scholar 

  • Baron C, Bousser MG, Comar D, Soussaline F, Castaigne P (1981) Noninvasive tomographic study of cerebral blood flow and oxygen metabolism in vivo. Potentials, limitations, and clinical applications in cerebral ischemic disorders. Eur Neurol 20:273–284

    Article  PubMed  CAS  Google Scholar 

  • Bluestein HG (1978) Neurocytotoxic antibodies in serum of patients with systemic lupus erythematosus. Proc Natl Acad Sci U S A 75:3965–3969

    Article  PubMed  CAS  Google Scholar 

  • Bluestein HG, Williams GW, Steinberg AD (1981) Cerebrospinal fluid antibodies to neuronal cells: association with neuropsychiatric manifestations of systemic lupus erythematosus. Am J Med 70:240–246

    Article  PubMed  CAS  Google Scholar 

  • Bonfa E, Golombek SJ, Kaufman LD, Skelly S, Weissbach H, Brot N et al (1987) Association between lupus psychosis and anti-ribosomal P protein antibodies. N Engl J Med 317:265–271

    Article  PubMed  CAS  Google Scholar 

  • Brey RL, Holliday SL, Saklad AR, Navarrete MG, Hermosillo-Romo D, Stallworth CL et al (2002) Neuropsychiatric Syndromes in lupus: prevalence using standardized definitions. Neurology 58:1214–1220

    Article  PubMed  CAS  Google Scholar 

  • Brooks WM, Sabet A, Sibbitt WL Jr, Barker PB, Van Zijl PC, Duyn JH et al (1997) Neurochemistry of brain lesions determined by spectroscopic imaging in systemic lupus erythematosus. J Rheumatol 24:2323–2329

    PubMed  CAS  Google Scholar 

  • Bruyn GA (1995) Controversies in lupus: nervous System involvement. Ann Rheum Dis 54:159–167

    Article  PubMed  CAS  Google Scholar 

  • Canadian Hydroxychloroquine Study Group (1991) A randomized study of the effect of with-drawing hydroxychloroquine sulfate in systemic lupus erythematosus. N Engl J Med 324: 150–154

    Article  Google Scholar 

  • Carbotte RM, Denburg SD, Denburg JA, Nahmias C, Garnett ES (1992) Fluctuating cognitive abnormalities and cerebral glucose metabolism in neuropsychiatric systemic lupus erythematosus. J Neurol Neurosurg Psychiatry 55:1054–1059

    Article  PubMed  CAS  Google Scholar 

  • Carbotte RM, Denburg SD, Denburg JA (1995) Cognitive deficit associated with rheumatic diseases: neuropsychological perspectives. Arthritis Rheum 38:1363–1374

    Article  PubMed  CAS  Google Scholar 

  • Carlomagno S, Migliaresi S, Ambrosone L, Sannino M, Sanges G, Di Iorio G (2000) Cognitive impairment in systemic lupus erythematosus: a follow-up study. J Neurol 247:273–279

    Article  PubMed  CAS  Google Scholar 

  • Cervera R, Khamashta MA, Font J, Sebastiani GD, Gil A, Lavilla P et al (1999) Morbidity and mortality in systemic lupus erythematosus during a 5-year period. A multicenter prospective study of 1,000 patients. European Working Party on Systemic Lupus Erythematosus. Mediane (Baltimore) 78:167–175

    Article  CAS  Google Scholar 

  • Chan TM, Li FK, Tang CS, Wong RW, Fang GX, Ji YL et al (2000) Efficacy of mycophenolate mofetil in patients with diffuse proliferative lupus nephritis. Hong Kong-Guangzhou Nephrology Study Group. N Engl J Med 343:1156–1162

    Article  PubMed  CAS  Google Scholar 

  • Chawluk JB, Alavi A, Dann R, Hurtig HI, Bais S, Kushner MJ et al (1987) Positron emission tomography in aging and dementia: effect of cerebral atrophy. J Nucl Med 28:431–437

    PubMed  CAS  Google Scholar 

  • Chen JJ, Shiau YC, Wang JJ, Ho ST, Kao A (2002) Abnormal regional cerebral blood flow in primary antiphospholipid antibody Syndrome patients with normal magnetic resonance imaging findings. A preliminary report. Scand J Rheumatol 31:89–93

    Article  PubMed  CAS  Google Scholar 

  • Chinn RJ, Wilkinson ID, Hall-Craggs MA, Paley MN, Shortall E, Carter et al (1997) Magnetic resonance imaging of the brain and cerebral proton spectroscopy in patients with systemic lupus erythematosus. Arthritis Rheum 40:36–46

    Article  PubMed  CAS  Google Scholar 

  • Christenson RH, Behlmer P, Howard JF Jr, Winfield JB, Silverman LM (1983) Interpretation of cerebrospinal fluid protein assays in various neurologic diseases. Clin Chem 29:1028–1030

    PubMed  CAS  Google Scholar 

  • Cohen SB, Hurd ER (1981) Neurological complications of connective tissue and other “collagen-vascular” diseases. Semin Arthritis Rheum 11:190–212

    Article  PubMed  CAS  Google Scholar 

  • Colamussi P, Giganti M, Cittanti C, Dovigo L, Trotta F, Tola MR et al (1995) Brain single-photon emission tomography with 99mTc-HMPAO in neuropsychiatric systemic lupus erythematosus: relations with EEG and MRI findings and clinical manifestations. Eur J Nucl Med 22:17–24

    Article  PubMed  CAS  Google Scholar 

  • Crowther MA, Ginsberg JS, Julian I, Deuburg I, Hirsh I et al. (2003) A comparison of two intensives of warfarin for the prevention of recurrent thrombosis in patients with antiphospholipid antibody Syndrome. NEJM 349:1133–1138

    Article  PubMed  CAS  Google Scholar 

  • Csepany T, Gulyas B, Tron L, Szakall S, Kiss E, Kollar J et al (1997) Cerebral positron emission tomographic study in systemic lupus erythematosus. Orv Hetil 138:1947–1952

    PubMed  CAS  Google Scholar 

  • Dafny N, Prieto-Gomez B, Dong WQ, Reyes-Vazquez C (1996) Interferon modulates neuronal activity recorded from the hypothalamus, thalamus, hippocampus, amygdala and the somatosensory cortex. Brain Res 734:269–274

    Article  PubMed  CAS  Google Scholar 

  • De Jong BM, Pruim J, Sinnige LG, Beintema KD, Spronk PE, Bootsma H et al (1999) Regional specific changes of cerebral metabolism in systemic lupus erythematosus identified by positron emission tomography. Eur Neurol 41:187–193

    Article  PubMed  Google Scholar 

  • Dean GS, Tyrrell-Price J, Crawley E, Isenberg DA (2000) Cytokines and systemic lupus erythematosus. Ann Rheum Dis 59:243–251

    Article  PubMed  CAS  Google Scholar 

  • DeGiorgio LA, Konstantinov KN, Lee SC, Hardin JA, Volpe BT, Diamond B (2001) A subset of lupus anti-DNA antibodies cross-reacts with the NR2 glutamate receptor in systemic lupus erythematosus. Nat Med 7:1189–1193

    Article  PubMed  CAS  Google Scholar 

  • Denburg JA, Behmann SA (1994) Lymphocyte and neuronal antigens in neuropsychiatric lupus: presence of an elutable, immunoprecipitable lymphocyte/neuronal 52 kd reactivity. Ann Rheum Dis 53:304–308

    Article  PubMed  CAS  Google Scholar 

  • Devinsky O, Petito CK, Alonso DR (1988) Clinical and neuropathological findings in systemic lupus erythematosus: the role of vasculitis, heart emboli, and thrombotic thrombocytopenic purpura. Ann Neurol 23:380–384

    Article  PubMed  CAS  Google Scholar 

  • Diederichsen H, Pyndt IC (1970) Antibodies against neurons in a patient with systemic lupus erythematosus, cerebral palsy, and epilepsy. Brain 93:407–412

    Article  PubMed  CAS  Google Scholar 

  • Digre KB, Durcan FJ, Branch DW, Jacobson DM, Varner MW, Baringer JR (1989) Amaurosis fugax associated with antiphospholipid antibodies. Ann Neurol 25:228–232

    Article  PubMed  CAS  Google Scholar 

  • Ellis SG, Verity MA (1979) Central nervous System involvement in systemic lupus erythematosus: a review of neuropathologic findings in 57 cases, 1955–1977. Semin Arthritis Rheum 8: 212–221

    Article  PubMed  CAS  Google Scholar 

  • Emmi L, Bergamini C, Spinelli A, Liotta F, Marchione T, Caldini A et al (1997) Possible pathogenetic role of activated platelets in the primary antiphospholipid Syndrome involving the central nervous System. Ann N Y Acad Sei 823:188–200

    Article  CAS  Google Scholar 

  • Emmi L, Bramati M, De Cristofaro MT, Mascalchi M, Dal Pozzo G, Marconi GP et al (1993) MRI and SPECT investigations of the CNS in SLE patients. Clin Exp Rheumatol 11:13–20

    PubMed  CAS  Google Scholar 

  • Falcini F, de Cristofaro MT, Ermini M, Guarnieri M, Massai G, Olmastroni M et al (1998) Regional cerebral blood flow in juvenile systemic lupus erythematosus: a prospective SPECT study. Single photon emission computed tomography (see comments). J Rheumatol 25:583–588

    PubMed  CAS  Google Scholar 

  • Fazekas F, Alavi A, Chawluk JB, Zimmerman RA, Hackney D, Bilaniuk L et al (1989) Comparison of CT, MR, and PET in Alzheimers dementia and normal aging. J Nucl Med 30:1607–1615

    PubMed  CAS  Google Scholar 

  • Feeney DM, Baron JC (1986) Diaschisis. Stroke 17:817–830

    Article  PubMed  CAS  Google Scholar 

  • Ferraccioli G, di Poi E, di Gregorio F, Giacomuzzi F, Guerra U (1999) Changes in regional cerebral blood flow after a cold hand test in systemic lupus erythematosus patients with Raynaud’s Syndrome. Lancet 354:2135–2136

    Article  PubMed  CAS  Google Scholar 

  • Fisk JD, Eastwood B, Sherwood G, Hanly JG (1993) Patterns of cognitive impairment in patients with systemic lupus erythematosus. Br J Rheumatol 32:458–462

    Article  PubMed  CAS  Google Scholar 

  • Folstein MF, Folstein SE, McHugh PR (1975) “Mini-mental State”. A practical method for grading the cognitive State of patients for the clinician. J Psychiatr Res 12:189–198

    Article  PubMed  CAS  Google Scholar 

  • Friedman SD, Stidley CA, Brooks WM, Hart BL, Sibbitt WL Jr (1998) Brain injury and neurometabolic abnormalities in systemic lupus erythematosus. Radiology 209:79–84

    PubMed  CAS  Google Scholar 

  • Furie R, Ishikawa T, Dhawan V, Eideiberg D (1994) Alternating hemichorea in primary antiphospholipid Syndrome: evidence for contralateral striatal hypermetabolism. Neurology 44:2197–2199

    Article  PubMed  CAS  Google Scholar 

  • Futrell N, Millikan C (1989) Frequency, etiology, and prevention of stroke in patients with systemic lupus erythematosus (see comments). Stroke 20:583–591

    Article  PubMed  CAS  Google Scholar 

  • Galeazzi M, Annunziata P, Sebastiani GD, Bellisai F, Campanella V, Ferrara GB et al (2000) Antiganglioside antibodies in a large cohort of European patients with systemic lupus erythematosus: clinical, serological, and HLA class II gene associations. European Concerted Action on the Immunogenetics of SLE. J Rheumatol 27:135–141

    PubMed  CAS  Google Scholar 

  • George MS, Ketter TA, Post RM (1993) SPECT and PET imaging in mood disorders. J Clin Psychiatry 54[Suppl]:6–13

    PubMed  Google Scholar 

  • Gilad R, Lampl Y, Eshel Y, Barak V, Sarova-Pinhas I (1997) Cerebrospinal fluid soluble interleukin-2 receptor in cerebral lupus. Br J Rheumatol 36:190–193

    Article  CAS  Google Scholar 

  • Gonzalez-Crespo MR, Blanco FJ, Ramos A, Ciruelo E, Mateo I, Lopez Pino MA et al (1995) Magnetic resonance imaging of the brain in systemic lupus erythematosus. Br J Rheumatol 34: 1055–1060

    Article  PubMed  CAS  Google Scholar 

  • Griffey RH, Brown MS, Bankhurst AD, Sibbitt RR, Sibbitt WL Jr (1990) Depletion of high-energy phosphates in the central nervous System of patients with systemic lupus erythematosus, as determined by phosphorus-31 nuclear magnetic resonance spectroscopy. Arthritis Rheum 33:827–833

    Article  PubMed  CAS  Google Scholar 

  • Grunwald F, Schomburg A, Badali A, Ruhlmann J, Pavics L, Biersack HJ (1995) 18FDG PET and acetazolamide-enhanced 99mTc-HMPAO SPET in systemic lupus erythematosus. Eur J Nucl Med 22:1073–1077

    Article  PubMed  CAS  Google Scholar 

  • Hachulla E, Michon-Pasturel U, Leys D, Pruvo JP, Queyrel V, Masy E et al (1998) Cerebral magnetic resonance imaging in patients with or without antiphospholipid antibodies. Lupus 7: 124–131

    Article  PubMed  CAS  Google Scholar 

  • Hanly JG (1998) Single photon emission computed tomography scanning in neuropsychiatric systemic lupus erythematosus (editorial; comment). J Rheumatol 25:401–403

    PubMed  CAS  Google Scholar 

  • Hanly JG, Liang MH (1997) Cognitive disorders in systemic lupus erythematosus. Epidemiologie and clinical issues. Ann N Y Acad Sci 823:60–68

    Article  CAS  Google Scholar 

  • Hanly JG, Cassell K, Fisk JD (1997) Cognitive funetion in systemic lupus erythematosus: results of a 5-year prospective study. Arthritis Rheum 40:1542–1543

    Article  CAS  Google Scholar 

  • Hanly JG, Fisk JD, Sherwood G, Jones E, Jones JV, Eastwood B (1992) Cognitive impairment in patients with systemic lupus erythematosus. J Rheumatol 19:562–567

    PubMed  CAS  Google Scholar 

  • Hanly JG, Hong C, Smith S, Fisk JD (1999) A prospective analysis of cognitive funetion and anti-cardiolipin antibodies in systemic lupus erythematosus. Arthritis Rheum 42:728–734

    Article  PubMed  CAS  Google Scholar 

  • Hanson VG, Horowitz M, Rosenbluth D, Spiera H, Puszkin S (1992) Systemic lupus erythematosus patients with central nervous System involvement show autoantibodies to a 50-kD neuronal membrane protein. J Exp Med 176:565–573

    Article  PubMed  CAS  Google Scholar 

  • Harris EN, Hughes GR (1985) Cerebral disease in systemic lupus erythematosus. Springer Semin Immunopathol 8:251–266

    Article  PubMed  CAS  Google Scholar 

  • Hay EM, Black D, Huddy A, Creed F, Tomenson B, Bernstein RM et al (1992) Psychiatric disorder and cognitive impairment in systemic lupus erythematosus. Arthritis Rheum 35:411–416

    Article  PubMed  CAS  Google Scholar 

  • Hay EM, Huddy A, Black D, Mbaya P, Tomenson B, Bernstein RM et al (1994) A prospective study of Psychiatric disorder and cognitive function in systemic lupus erythematosus. Ann Rheum Dis 53:298–303

    Article  PubMed  CAS  Google Scholar 

  • Higashi K, Nishikawa T, Seki H, Oguchi M, Nambu Y, Ueda Y et al (1998) Comparison of fluorine-18-FDG PET and thallium-201 SPECT in evaluation of lung Cancer. J Nucl Med 39:9–15

    PubMed  CAS  Google Scholar 

  • Hilker R, Thiel A, Geisen C, Rudolf J (2000) Cerebral blood flow and glucose metabolism in multi-infarct-dementia related to primary antiphospholipid antibody Syndrome. Lupus 9:311–316

    Article  PubMed  CAS  Google Scholar 

  • Hiraiwa M, Nonaka C, Abe T, Iio M (1983) Positron emission tomography in systemic lupus erythematosus: relation of cerebral vasculitis to PET findings. AJNR Am J Neuroradiol 4:541–543

    PubMed  CAS  Google Scholar 

  • Hirohata S, Hayakawa K (1999) Enhanced interleukin-6 messenger RNA expression by neuronal cells in a patient with neuropsychiatric systemic lupus erythematosus. Arthritis Rheum 42:2729–2730

    Article  PubMed  CAS  Google Scholar 

  • Hirohata S, Miyamoto T (1990) Elevated levels of interleukin-6 in cerebrospinal fluid from patients with systemic lupus erythematosus and central nervous System involvement. Arthritis Rheum 33:644–649

    Article  PubMed  CAS  Google Scholar 

  • Hochberg MC, Perlmutter DL, Medsger TA, Steen V, Weisman MH, White B et al (1995) Prevalence of self-reported physician-diagnosed systemic lupus erythematosus in the USA. Lupus 4:454–456

    Article  PubMed  CAS  Google Scholar 

  • How A, Dent PB, Liao SK, Denburg JA (1985) Antineuronal antibodies in neuropsychiatric systemic lupus erythematosus. Arthritis 28:789–795

    Article  CAS  Google Scholar 

  • Huang WS, Chiu PY, Tsai CH, Kao A, Lee CC (2002) Objective evidence of abnormal regional cerebral blood flow in patients with systemic lupus erythematosus on Tc-99m ECD brain SPECT. Rheumatol Int 22:178–181

    Article  PubMed  CAS  Google Scholar 

  • Isenberg DA, Liang MH (1999) CNS lupus — where do we go from here? Lupus 8:1–2

    Article  PubMed  CAS  Google Scholar 

  • Ishikawa O, Ohnishi K, Miyachi Y, Ishizaka H (1994) Cerebral lesions in systemic lupus erythematosus detected by magnetic resonance imaging. Relationship to anticardiolipin antibody. J Rheumatol 21:87–90

    PubMed  CAS  Google Scholar 

  • Isshi K, Hirohata S (1998) Differential roles of the anti-ribosomal P antibody and antineuronal antibody in the pathogenesis of central nervous System involvement in systemic lupus erythematosus. Arthritis Rheum 41:1819–1827

    Article  PubMed  CAS  Google Scholar 

  • Jacobson MW, Rapport LJ, Keenan PA, Coleman RD, Tietjen, GE (1999) Neuropsychological deficits associated with antiphospholipid antibodies. J Clin Exp Neuropsychol 21:251–264

    Article  PubMed  CAS  Google Scholar 

  • Jara LJ, Irigoyen L, Ortiz MJ, Zazueta B, Bravo G, Espinoza LR (1998) Prolactin and interleukin-6 in neuropsychiatric lupus erythematosus. Clin Rheumatol 17:110–114

    Article  PubMed  CAS  Google Scholar 

  • Jarek MJ, West SG, Baker MR, Rak KM (1994) Magnetic resonance imaging in systemic lupus erythematosus patients without a history of neuropsychiatric lupus erythematosus. Arthritis Rheum 37:1609–1613

    Article  PubMed  CAS  Google Scholar 

  • Juengling FD, Ebert D, Gut O, Engelbrecht MA, Rasenack J, Nitzsche EU et al (2000) Prefrontal cortical hypometabolism during low-dose interferon alpha treatment. Psychopharmacology (Berl) 152:383–389

    Article  CAS  Google Scholar 

  • Kaell AT, Shetty M, Lee BC, Lockshin MD (1986) The diversity of neurologic events in systemic lupus erythematosus. Prospective clinical and computed tomographic Classification of 82 events in 71 patients. Arch Neurol 43:273–276

    Article  PubMed  CAS  Google Scholar 

  • Kao CH, Ho YJ, Lan JL, ChangLai SP, Liao KK, Chieng PU (1999a) Discrepancy between regional cerebral blood flow and glucose metabolism of the brain in systemic lupus erythematosus patients with normal brain magnetic resonance imaging findings. Arthritis Rheum 42:61–68

    Article  PubMed  CAS  Google Scholar 

  • Kao CH, Lan JL, ChangLai SP, Liao KK, Yen RF, Chieng et al (1999b) The role of FDG-PET, HM-PAO-SPET and MRI in the detection of brain involvement in patients with systemic lupus erythematosus. Eur J Nucl Med 26:129–134

    Article  PubMed  CAS  Google Scholar 

  • Karassa FB, Ioannidis JP, Boki KA, Touloumi G, Argyropoulou MI, Strigaris KA et al (2000) Predictors of clinical outcome and radiologic progression in patients with neuropsychiatric manifestations of systemic lupus erythematosus. Am J Med 109:628–634

    Article  PubMed  CAS  Google Scholar 

  • Keenan PA, Jacobson MW, Soleymani RM, Mayes MD, Stress ME et al (1996) The effect on memory of chronic Prednisone treatment in patients with systemic disease. Neurology 47:1396–1402

    Article  PubMed  CAS  Google Scholar 

  • Khamashta MA, Cuadrado MJ, Mujic F, Taub NA, Hunt BJ, Hughes GRV (1995) The management of thrombosis in the antiphospholipid-antibody Syndrome. N Engl J Med 332:993–997

    Article  PubMed  CAS  Google Scholar 

  • Khoshbin S, Glanz BI, Schur PH (1999) Neuropsychiatric Syndromes in systemic lupus erythematosus: a new look. Clin Exp Rheumatol 17:395–398

    PubMed  CAS  Google Scholar 

  • Kikukawa K, Toyama H, Katayama M, Nishimura T, Ejiri K, Minami K et al (2000) Early and delayed Tc-99m ECD brain SPECT in SLE patients with CNS involvement. Ann Nucl Med 14: 25–32

    Article  PubMed  CAS  Google Scholar 

  • Klein R, Richter C, Berg PA (1991) Antibodies against central nervous System tissue (anti-CNS) detected by ELISA and Western blotting: marker antibodies for neuropsychiatric manifestations in connective tissue diseases. Autoimmunity 10:133–144

    Article  PubMed  CAS  Google Scholar 

  • Kodama K, Okada S, Hino T, Takabayashi K, Nawata Y, Uchida Y et al (1995) Single photon emission computed tomography in systemic lupus erythematosus with Psychiatric Symptoms. J Neurol Neurosurg Psychiatry 58:307–311

    Article  PubMed  CAS  Google Scholar 

  • Koren E, Reichlin MW, Koscec M, Fugate RD, Reichlin M (1992) Autoantibodies to the ribosomal P proteins react with a plasma membrane-related target on human cells. J Clin Invest 89: 1236–1241

    Article  PubMed  CAS  Google Scholar 

  • Kovacs B, Lafferty TL, Brent LH, DeHoratius RJ (2000) Transverse myelopathy in systemic lupus erythematosus: an analysis of 14 cases and review of the literature. Ann Rheum Dis 59: 120–124

    Article  PubMed  CAS  Google Scholar 

  • Kovacs JA, Urowitz MB, Gladman DD, Zeman R (1995) The use of Single photon emission computerized tomography in neuropsychiatric SLE: a pilot study. J Rheumatol 22:1247–1253

    PubMed  CAS  Google Scholar 

  • Kozora E, West SG, Kotzin BL, Julian L, Porter S, Bigler E (1998) Magnetic resonance imaging abnormalities and cognitive deficits in systemic lupus erythematosus patients without overt central nervous System disease. Arthritis Rheum 41:41–47

    Article  PubMed  CAS  Google Scholar 

  • Kumral E, Evyapan D, Keser G, Kabasakal Y, Oksel F, Aksu K et al (2002) Detection of microembolic Signals in patients with neuropsychiatric lupus erythematosus. Eur Neurol 47:131–135

    Article  PubMed  CAS  Google Scholar 

  • Kushner MJ, Chawluk J, Fazekas F, Mandell B, Burke A, Jaggi J et al (1987) Cerebral blood flow in systemic lupus erythematosus with or without cerebral complications. Neurology 37:1596–1598

    Article  PubMed  CAS  Google Scholar 

  • Kuwabara Y, Ichiya Y, Otsuka M, Tahara T, Fukumura T, Gunasekera R et al (1990) Differential diagnosis of bilateral parietal abnormalities in 1-123 IMP SPECT imaging. Clin Nucl Med 15: 893–899

    Article  PubMed  CAS  Google Scholar 

  • Lai NS, Lan JL (2000) Evaluation of cerebrospinal anticardiolipin antibodies in lupus patients with neuropsychiatric manifestations. Lupus 9:353–357

    Article  PubMed  CAS  Google Scholar 

  • Lee SC, Dickson DW, Liu W, Brosnan CF (1993) Induction of nitric oxide synthase activity in human astrocytes by interleukin-1 beta and interferon-gamma. J Neuroimmunol 46:19–24

    Article  PubMed  CAS  Google Scholar 

  • Levine SR, Welch KM(1987) The spectrum of neurologic disease associated with antiphospholipid antibodies. Lupus anticoagulants and anticardiolipin antibodies (review). Arch Neurol 44:876–883

    Article  PubMed  CAS  Google Scholar 

  • Lewis SW, Ford RA, Syed GM, Reveley AM, Toone BK (1992) A controlled study of 99mTc-HM-PAO single-photon emission imaging in chronic schizophrenia. Psychol Med 22:27–35

    Article  PubMed  CAS  Google Scholar 

  • Liem MD, Gzesh DJ, Flanders AE (1996) MRI and angiographic diagnosis of lupus cerebral vasculitis. Neuroradiology 38:134–136

    Article  PubMed  CAS  Google Scholar 

  • Lin WY, Wang SJ, Yen TC, Lan JL (1997) Technetium-99m-HMPAO brain SPECT in systemic lupus erythematosus with CNS involvement. J Nucl Med 38:1112–1115

    CAS  Google Scholar 

  • Lindal E, Thorlacius S, Steinsson K, Stefansson JG (1995) Psychiatric disorders among subjects with systemic lupus erythematosus in an unselected population. Scand J Rheumatol 24:346–351

    Article  PubMed  CAS  Google Scholar 

  • Loessner A, Alavi A, Lewandrowski KU, Mozley D, Souder E, Gur RE (1995) Regional cerebral function determined by FDG-PET in healthy volunteers: normal patterns and changes with age. J Nucl Med 36:1141–1149

    PubMed  CAS  Google Scholar 

  • Loizou S, McCrea JD, Rudge AC, Reynolds R, Boyle CC, Harris EN (1985) Measurement of anti-cardiolipin antibodies by an enzyme-linked immunosorbent assay (ELISA): standardization and quantitation of results. Clin Exp Immunol 62:738–745

    PubMed  CAS  Google Scholar 

  • Long AA, Denburg SD, Carbotte RM, Singal DP, Denburg JA (1990) Serum lymphocytotoxic antibodies and neurocognitive function in systemic lupus erythematosus. Ann Rheum Dis 49: 249–253

    Article  PubMed  CAS  Google Scholar 

  • Maeshima E, Maeshima S, Yamada Y, Yukawa S (1993) Antiphospholipid antibodies and regional cerebral blood flow in systemic lupus erythematosus (Japanese). Ryumachi 33:125–130

    PubMed  CAS  Google Scholar 

  • Maeshima E, Yamada Y, Yukawa S, Nomoto H (1992) Higher cortical dysfunction, antiphospholipid antibodies and neuroradiological examinations in systemic lupus erythematosus. Intern Med 31:1169–1174

    Article  PubMed  CAS  Google Scholar 

  • Markus HS, Hopkinson N (1992) Migraine and headache in systemic lupus erythematosus and their relationship with antibodies against phospholipids. J Neurol 239:39–42

    Article  PubMed  CAS  Google Scholar 

  • Marullo S, Clauvel JP, Intrator L, Danon F, Brouet JC, Oksenhendler E (1993) Lupoid sclerosis with antiphospholipid and antimyelin antibodies. J Rheumatol 20:747–749

    PubMed  CAS  Google Scholar 

  • Mason LJ, Isenberg DA (1998) Immunopathogenesis of SLE. Baillieres Clin Rheumatol 12:385–403

    Article  PubMed  CAS  Google Scholar 

  • Mathieu A, Sanna G, Mameli A, Pinna C, Vacca A, Cauli A et al (2002) Sustained normalization of cerebral blood-flow after iloprost therapy in a patient with neuropsychiatric systemic lupus erythematosus. Lupus 11:52–56

    Article  PubMed  CAS  Google Scholar 

  • Matsukawa Y, Nishinarita S, Hayama T, Sawada S, Horie T (1993) Clinical significance of electro-encephalograph in patients with systemic lupus erythematosus. Ryumachi 33:20–28

    PubMed  CAS  Google Scholar 

  • Matsukawa Y, Sawada S, Hayama T, Usui H, Horie T (1994) Suicide in patients with systemic lupus erythematosus: a clinical analysis of seven suicidal patients. Lupus 3:31–35

    Article  PubMed  CAS  Google Scholar 

  • McDonald EM, Mann AH, Thomas HC(1987) Interferons as mediators of Psychiatric morbidity. An investigation in a trial of recombinant alpha-interferon in hepatitis-B carriers. Lancet 2:1175–1178

    Article  PubMed  CAS  Google Scholar 

  • Meinao IM, Sato EI, Andrade LE, Ferraz MB, Atra E (1996) Controlled trial with chloroquine diphosphate in systemic lupus erythematosus. Lupus 5:237–241

    Article  PubMed  CAS  Google Scholar 

  • Menon S, Jameson-Shortall E, Newman SP, Hall-Craggs MR, Chinn R, Isenberg DA (1999) A longitudinal study of anticardiolipin antibody levels and cognitive functioning in systemic lupus erythematosus. Arthritis Rheum 42:735–741

    Article  PubMed  CAS  Google Scholar 

  • Meusser S, Rubbert A, Manger B, Bock E, Platsch G, Feistel H et al (1996) 99m-Tc-HMPAO-SPECT in diagnosis of early cerebral vasculitis. Rheumatol Int 16:37–42

    Article  PubMed  CAS  Google Scholar 

  • Miller DH, Buchanan N, Barker G, Morrissey SP, Kendall BE, Rudge P et al (1992) Gadolinium-enhanced magnetic resonance imaging of the central nervous System in systemic lupus erythematosus. J Neurol 239:460–464

    Article  PubMed  CAS  Google Scholar 

  • Mitsias P, Levine SR (1994) Large cerebral vessel occlusive disease in systemic lupus erythematosus. Neurology 44:385–393

    Article  PubMed  CAS  Google Scholar 

  • Morita A, Kato T (2000) Improvement of cerebral perfusion with argatroban in a patient with antiphospholipid Syndrome. Ryumachi 40:824–827

    PubMed  CAS  Google Scholar 

  • Mosek A, Yust I, Treves TA, Vardinon N, Korczyn AD, Chapman J (2000) Dementia and antiphospholipid antibodies. Dement Geriatr Cogn Disord 11:36–38

    Article  PubMed  CAS  Google Scholar 

  • Naarendorp M, Spiera H (1998) Sudden sensorineural hearing loss in patients with systemic lupus erythematosus or lupus-like Syndromes and antiphospholipid antibodies (see comments). J Rheumatol 25:589–592

    PubMed  CAS  Google Scholar 

  • Neuwelt CM, Lacks S, Kaye BR, Ellman JB, Borenstein DG (1995) Role of intravenous cyclophosphamide in the treatment of severe neuropsychiatric systemic lupus erythematosus. Am J Med 98:32–41

    Article  PubMed  CAS  Google Scholar 

  • Nomura K, Yamano S, Ikeda Y, Yamada H, Fujimoto T, Minami S et al (1999) Asymptomatic cerebrovascular lesions detected by magnetic resonance imaging in patients with systemic lupus erythematosus lacking a history of neuropsychiatric events. Intern Med 38:785–795

    Article  PubMed  CAS  Google Scholar 

  • Omdal R, Husby G, Mellgren SI (1995) Mental health Status in systemic lupus erythematosus. Scand J Rheumatol 24:142–145

    Article  PubMed  CAS  Google Scholar 

  • Otte A (2001) Das Halswirbelsäulen-Schleudertrauma: neue Wege der funktionellen Bildgebung des Gehirns — ein Ratgeber für Ärzte und Betroffene. Springer, Berlin Heidelberg New York

    Book  Google Scholar 

  • Otte A, Mueller-Brand J, Fierz L (1995) Brain SPECT Undings in late whiplash Syndrome (letter). Lancet 345:1513–1513

    Article  PubMed  CAS  Google Scholar 

  • Otte A, Ettlin TM, Nitzsche EU, Wächter K, Hoegerle S, Simon GH et al (1997a) PET and SPECT in whiplash Syndrome: a new approach to a forgotten brain? J Neurol Neurosurg Psychiatry 63: 368–372

    Article  PubMed  CAS  Google Scholar 

  • Otte A, Weiner SM, Peter HH, Mueller-Brand J, Goetze M, Moser E et al (1997b) Brain glucose utilization in systemic lupus erythematosus with neuropsychiatric Symptoms: a controlled positron emission tomography study. Eur J Nucl Med 24:787–791

    PubMed  CAS  Google Scholar 

  • Otte A, Weiner SM, Hoegerle S, Wolf R, Juengling FD, Peter HH et al (1998) Neuropsychiatric systemic lupus erythematosus before and after immunosuppressive treatment: a FDG PET study. Lupus 7:57–59

    Article  PubMed  CAS  Google Scholar 

  • Perani D, Di Piero V, Vallar G, Cappa S, Messa C, Bottini G et al (1988) Technetium-99m HM-PAO-SPECT study of regional cerebral perfusion in early Alzheimers disease. J Nucl Med 29: 1507–1514

    PubMed  CAS  Google Scholar 

  • Petri M, Perez-Gutthann S, Spence D, Hochberg MC (1992) Risk factors for coronary artery disease in patients with systemic lupus erythematosus. Am J Med 93:513–519

    Article  PubMed  CAS  Google Scholar 

  • Petri M, Roubenoff R, Dallal GE, Nadeau MR, Seihub J, Rosenberg ICH (1996) Plasma homocysteine as a risk factor for atherothrombotic events in systemic lupus erythematosus. Lancet 348:1120–1124

    Article  PubMed  CAS  Google Scholar 

  • Pinching AJ, Travers RL, Hughes GR, Jones T, Moss S (1978) Oxygen-15 brain scanning for detection of cerebral involvement in systemic lupus erythematosus. Lancet 1:898–900

    Article  PubMed  CAS  Google Scholar 

  • Provenzale JM, Barboriak DP, Allen NB, Ortel TL (1996) Patients with antiphospholipid antibodies: CT and MR findings of the brain. AJR Am J Roentgenol 167:1573–1578

    Article  PubMed  CAS  Google Scholar 

  • Provenzale JM, Barboriak DP, Allen NB, Ortel TL (1998) Antiphospholipid antibodies: findings at arteriography. AJNR Am J Neuroradiol 19:611–616

    PubMed  CAS  Google Scholar 

  • Provenzale JM, Barboriak DP, Gaensler EH, Robertson RL, Mercer B (1994) Lupus-related myelitis: serial MR findings. AJNR Am J Neuroradiol 15:1911–1917

    PubMed  CAS  Google Scholar 

  • Quismorio FP, Friou GJ (1972) Antibodies reactive with neurons in SLE patients with neuropsychiatric manifestations. Int Arch Allergy Appl Immunol 43:740–748

    Article  PubMed  CAS  Google Scholar 

  • Rahman P, Gladman DD, Urowitz MB, Yuen K, Halle” D, Bruce IN (1999) The cholesterol lowering effect of antimalarial drugs is enhanced in patients with lupus taking corticosteroid drugs. J Rheumatol 26:325–330

    PubMed  CAS  Google Scholar 

  • Rapport MM, Karpiak SE, Mahadik SP (1979) Biological activities of antibodies injected into the brain. Fed Proc 38:2391–2396

    PubMed  CAS  Google Scholar 

  • Reiff A, Miller J, Shaham B, Bernstein B, Szer IS (1997) Childhood central nervous System lupus: longitudinal assessment using Single photon emission computed tomography. J Rheumatol 24:2461–2465

    CAS  Google Scholar 

  • Robbins ML, Kornguth SE, Bell CL, Kalinke T, England D, Turski P et al (1988) Antineurofilament antibody evaluation in neuropsychiatric systemic lupus erythematosus. Combination with anticardiolipin antibody assay and magnetic resonance imaging. Arthritis Rheum 31: 623–631

    Article  PubMed  CAS  Google Scholar 

  • Rodriguez G, Nobili F, De Carli F, Francione S, Marenco S, Celestino MA et al (1993) Regional cerebral blood flow in chronic stroke patients. Stroke 24:94–99

    Article  PubMed  CAS  Google Scholar 

  • Rogers MP, Waterhouse E, Nagel JS, Roberts NW, Stern SH, Fräser P et al (1992) 1-123 iofetamine SPECT scan in systemic lupus erythematosus patients with cognitive and other minor neuropsychiatric Symptoms: a pilot study. Lupus 1:215–219

    Article  PubMed  CAS  Google Scholar 

  • Rood MJ, Haverman JF, van Duinen SG, Breedveld FC, Verschuuren JJ, Huizinga TW (2001) CNS involvement in systemic lupus erythematosus: a case with remarkable histopathological findings. Ann Rheum Dis 60:299–300

    Article  PubMed  CAS  Google Scholar 

  • Rosner S, Ginzier EM, Diamond HS, Weiner M, Schlesinger, M et al (1982) A multicenter study of outcome in systemic lupus erythematosus. II. Causes of death. Arthritis Rheum 25:612–617

    Article  PubMed  CAS  Google Scholar 

  • Roubey RA, Maldonado MA, Byrd SN (1996) Comparison of an enzyme-linked immunosorbent assay for antibodies to beta 2-glycoprotein I and a conventional anticardiolipin immunoassay. Arthritis Rheum 39:1606–1607

    Article  PubMed  CAS  Google Scholar 

  • Rovaris M, Filippi M (2000) The value of new magnetic resonance techniques in multiple sclerosis. Curr Opin Neurol 13:249–254

    Article  PubMed  CAS  Google Scholar 

  • Rubbert A, Marienhagen J, Pirner K, Manger B, Grebmeier J, Engelhardt et al (1993) Single-photon-emission computed tomography analysis of cerebral blood flow in the evaluation of central nervous system involvement in patients with systemic lupus erythematosus (see comments). Arthritis Rheum 36:1253–1262

    Article  PubMed  CAS  Google Scholar 

  • Rubin LA, Urowitz MB, Gladman DD (1985) Mortality in systemic lupus erythematosus: the bimodal pattern revisited. Q J Med 55:87–98

    PubMed  CAS  Google Scholar 

  • Ruiz-Irastorza G, Khamashta MA, Castellino G, Hughes GR (2001) Systemic lupus erythematosus. Lancet 357:1027–1032

    Article  PubMed  CAS  Google Scholar 

  • Sabbadini MG, Manfredi AA, Bozzolo E, Ferrario L, Rugarli C, Scorza R et al (1999) Central nervous system involvement in systemic lupus erythematosus patients without overt neuropsychiatric manifestations (see comments). Lupus 8:11–19

    Article  PubMed  CAS  Google Scholar 

  • Sabet A, Sibbitt WL, Jr., Stidley CA, Danska J, Brooks WM (1998) Neurometabolite markers of cerebral injury in the antiphospholipid antibody Syndrome of systemic lupus erythematosus. Stroke 29:2254–2260

    Article  PubMed  CAS  Google Scholar 

  • Sailer M, Burchert W, Ehrenheim C, Smid HG, Haas J, Wildhagen K et al (1997) Positron emission tomography and magnetic resonance imaging for cerebral involvement in patients with systemic lupus erythematosus. J Neurol 244:186–193

    Article  PubMed  CAS  Google Scholar 

  • Sato T, Uchiumi T, Ozawa T, Kikuchi M, Nakano M, Kominami R et al (1991) Autoantibodies against ribosomal proteins found with high frequency in patients with systemic lupus erythematosus with active disease. J Rheumatol 18:1681–1684

    PubMed  CAS  Google Scholar 

  • Schneebaum AB, Singleton JD, West SG, Blodgett JK, Allen LG, Cheronis JC et al (1991) Association of Psychiatric manifestations with antibodies to ribosomal P proteins in systemic lupus erythematosus. Am J Med 90:54–62

    Article  PubMed  CAS  Google Scholar 

  • Schwartz RB, Garada BM, Komaroff AL, Tice HM, Gleit M, Jolesz FA et al (1994) Detection of intracranial abnormalities in patients with chronic fatigue Syndrome: comparison of MR imaging and SPECT. AJR Am J Roentgenol 162:935–941

    Article  PubMed  CAS  Google Scholar 

  • Shen YY, Kao CH, Ho YJ, Lee JK (1999) Regional cerebral blood flow in patients with systemic lupus erythematosus. J Neuroimaging 9:160–164

    PubMed  CAS  Google Scholar 

  • Shiozawa S, Kuroki Y, Kim M, Hirohata S, Ogino T (1992) Interferon-alpha in lupus psychosis. Arthritis Rheum 35:417–422

    Article  PubMed  CAS  Google Scholar 

  • Shortall E, Isenberg D, Newman SP (1995) Factors associated with mood and mood disorders in SLE. Lupus 4:272–279

    Article  PubMed  CAS  Google Scholar 

  • Shrivastava A, Dwivedi S, Aggarwal A, Misra R (2001) Anti-cardiolipin and anti-beta2 glycoprotein I antibodies in Indian patients with systemic lupus erythematosus: association with the presence of seizures. Lupus 10:45–50

    Article  PubMed  CAS  Google Scholar 

  • Shuaib A, Barklay L, Lee MA, Suchowersky O (1989) Migraine and anti-phospholipid antibodies. Headache 29:42–45

    Article  PubMed  CAS  Google Scholar 

  • Sibbitt WL Jr, Brooks WM, Haseler LJ, Griffey RH, Frank LM, Hart BL et al (1995) Spin-spin relaxation of brain tissues in systemic lupus erythematosus: a method for increasing the sensitivity of magnetic resonance imaging for neuropsychiatric lupus. Arthritis Rheum 38:810–818

    Article  PubMed  Google Scholar 

  • Sibbitt WL Jr, Sibbitt RR, Brooks WM (1999) Neuroimaging in neuropsychiatric systemic lupus erythematosus. Arthritis Rheum 42:2026–2038

    Article  PubMed  Google Scholar 

  • Sibbitt WL Jr, Sibbitt RR, Griffey RH, Eckel C, Bankhurst AD (1989) Magnetic resonance and computed tomographic imaging in the evaluation of acute neuropsychiatric disease in systemic lupus erythematosus. Ann Rheum Dis 48:1014–1022

    Article  PubMed  Google Scholar 

  • Sibley JT, Olszynski WP, Decoteau WE, Sundaram MB (1992) The incidence and prognosis of central nervous system disease in systemic lupus erythematosus. J Rheumatol 19:47–52

    PubMed  CAS  Google Scholar 

  • Simon J, Simon O (1975) Effect of passive transfer of anti-brain antibodies to a normal recipient. Exp Neurol 47:523–534

    Article  PubMed  CAS  Google Scholar 

  • Stefan H, Kuhnen C, Biersack H J, Reichmann K(1987) Initial experience with 99m Tc-hexamethyl-propylene amine oxime (HM-PAO) Single photon emission computed tomography (SPECT) in patients with focal epilepsy. Epilepsy Res 1:134–138

    Article  PubMed  CAS  Google Scholar 

  • Stimmler MM, Coletti PM, Quismorio FP Jr (1993) Magnetic resonance imaging of the brain in neuropsychiatric systemic lupus erythematosus. Semin Arthritis Rheum 22:335–349

    Article  PubMed  CAS  Google Scholar 

  • Stoppe G, Wildhagen K, Seidel JW, Meyer GJ, Schober 0, Heintz P et al (1990) Positron emission tomography in neuropsychiatric lupus erythematosus (see comments). Neurology 40:304–308

    Article  PubMed  CAS  Google Scholar 

  • Sun KH, Liu WT, Tsai CY, Liao TS, Lin WM, Yu CL (1992) Inhibition of astrocyte proliferation and binding to brain tissue of anticardiolipin antibodies purified from lupus serum. Ann Rheum Dis 51:707–712

    Article  PubMed  CAS  Google Scholar 

  • Svenungsson E, Andersson M, Brundin L, van Vollenhoven R, Khademi M, Tarkowski A et al (2001) Increased levels of proinflammatory cytokines and nitric oxide metabolites in neuropsychiatric lupus erythematosus. Ann Rheum Dis 60:372–379

    Article  PubMed  CAS  Google Scholar 

  • Tan EM, Cohen AS, Fries JF, Masi AT, McShane DJ, Rothfield NF et al (1982) The 1982 revised criteria for the Classification of systemic lupus erythematosus. Arthritis Rheum 25:1271–1277

    Article  PubMed  CAS  Google Scholar 

  • Teh L-S, Isenberg DA (1994) Antiribosomal P protein antibodies in systemic lupus erythematosus. Arthritis Rheum 37:307–315

    Article  PubMed  CAS  Google Scholar 

  • Tokumaru S, Yoshikai T, Uchino A, Matsui M, Kuroda Y, Kudo S (2001) Technetium-99m-ECD SPECT in antiphospholipid antibody Syndrome: a drastic improvement in brain perfusion by antiplatelet therapy. Eur Radiol 11:2611–2615

    Article  PubMed  CAS  Google Scholar 

  • Toubi E, Khamashta MA, Panarra A, Hughes GRV (1995) Association of antiphospholipid antibodies with central nervous System disease in systemic lupus erythematosus. Am J Med 99: 397–401

    Article  PubMed  CAS  Google Scholar 

  • Trysberg E, Carlsten H, Tarkowski A (2000) Intrathecal cytokines in systemic lupus erythematosus with central nervous System involvement. Lupus 9:498–503

    Article  PubMed  CAS  Google Scholar 

  • Tsokos GC, Tsokos M, le Riche NG, Klippel JH (1986) A clinical and pathologic study of cerebrovascular disease in patients with systemic lupus erythematosus. Semin Arthritis Rheum 16:70–78

    Article  PubMed  CAS  Google Scholar 

  • Urowitz MB, Gladman DD (2000) How to improve morbidity and mortality in systemic lupus erythematosus. Rheumatology (Oxf) 39:238–244

    Article  CAS  Google Scholar 

  • Vaarala O, Alfthan G, Jauhiainen M, Leirisalo-Repo M, Aho K, Palosuo T (1993) Crossreaction between antibodies to oxidised low-density lipoprotein and to cardiolipin in systemic lupus erythematosus. Lancet 341:923–925

    Article  PubMed  CAS  Google Scholar 

  • Valentine AD, Meyers CA, Kling MA, Richelson E, Hauser P (1998) Mood and cognitive side effects of interferon-alpha therapy. Semin Oncol 1[Suppl l]:2539–2547

    Google Scholar 

  • Van Dam AP (1991) Diagnosis and pathogenesis of CNS lupus. Rheumatol Int 11:1–11

    Article  PubMed  Google Scholar 

  • Waldemar G, Bruhn P, Kristensen M, Johnsen A, Paulson OB, Lassen NA (1994) Heterogeneity of neocortical cerebral blood flow deficits in dementia of the Alzheimer type: a [99mTc]-d,l-HMPAO SPECT study. J Neurol Neurosurg Psychiatry 57:285–295

    Article  PubMed  CAS  Google Scholar 

  • Wallace DJ (1993) Plasmapheresis in lupus. Lupus 2:141–143

    Article  PubMed  CAS  Google Scholar 

  • Wallace DJ, Linker-Israeli M, Metzger AL, Stecher VJ (1993) The relevance of antimalarial therapy with regard to thrombosis, hypercholesterolemia and cytokines in SLE. Lupus 2[Suppl 1]:S13–S15

    Article  PubMed  Google Scholar 

  • Ward MM, Studenski S (1991) The time course of acute Psychiatric episodes in systemic lupus erythematosus. J Rheumatol 18:535–539

    PubMed  CAS  Google Scholar 

  • Waterloo K, Omdal R, Sjoholm H, Koldingsnes W, Jacobsen EA, Sundsfjord JA et al (2001) Neuropsychological dysfunction in systemic lupus erythematosus is not associated with changes in cerebral blood flow. J Neurol 248:595–602

    Article  PubMed  CAS  Google Scholar 

  • Weiner SM, Peter HH (2002) Neuropsychiatric involvement in systemic lupus erythematosus, part 1: clinical presentation and pathogenesis. Med Klin 97:730–737

    Article  CAS  Google Scholar 

  • Weiner SM, Klein R, Berg PA (2000a) A longitudinal study of autoantibodies against central nervous System tissue and gangliosides in connective tissue diseases. Rheumatol Int 19:83–88

    Article  PubMed  CAS  Google Scholar 

  • Weiner SM, Otte A, Schumacher M, Brink I, Juengling FD, Sobanksi T et al (2000b) Alterations of cerebral glucose metabolism indicate progress to severe morphological brain lesions in neuropsychiatric systemic lupus erythematosus. Lupus 9:386–389

    Article  PubMed  CAS  Google Scholar 

  • Weiner SM, Otte A, Schumacher M, Klein R, Gutfleisch J, Brink I et al (2000c) Diagnosis and monitoring of central nervous System involvement in systemic lupus erythematosus: value of F-18 fluorodeoxyglucose PET. Ann Rheum Dis 59:377–385

    Article  PubMed  CAS  Google Scholar 

  • West SG (1996) Lupus and the central nervous System. Curr Opin Rheumatol 8:408–414

    Article  PubMed  CAS  Google Scholar 

  • West SG, Emlen W, Wener MH, Kotzin BL (1995) Neuropsychiatric lupus erythematosus: a 10-year prospective study on the value of diagnostic tests. Am J Med 99:153–163

    Article  PubMed  CAS  Google Scholar 

  • Wilson WA, Gharavi AE, Piette JC (2001) International Classification criteria for antiphospholipid Syndrome: Synopsis of a post-conference Workshop held at the 9th international (Tours) aPL Symposium. Lupus 10:457–460

    Article  PubMed  CAS  Google Scholar 

  • Winfield JB, Shaw M, Silverman LM, Eisenberg RA, Wilson HA 3rd, Koffler D (1983) Intrathecal IgG synthesis and blood-brain barrier impairment in patients with systemic lupus erythematosus and central nervous System dysfunction. Am J Med 74:837–844

    Article  PubMed  CAS  Google Scholar 

  • Woods RP, Iacoboni M, Mazziotta JC (1994) Brief report: bilateral spreading cerebral hypoperfusion during spontaneous migraine headache. N Engl J Med 331:1689–1692

    Article  PubMed  CAS  Google Scholar 

  • Zimmerman RD, Fleming CA, Lee BC, Saint-Louis LA, Deck MD (1986) Periventricular hyper-intensity as seen by magnetic resonance: prevalence and significance. AJR Am J Roentgenol 146:443–450

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Medicine, Marienhospital, Ruhr University Bochum, Hoelkeskampring 40, 44625, Herne, Germany

    Stefan M. Weiner

  2. Division of Nuclear Medicine, University Hospital Ghent, De Pintelaan 185, 9000, Gent, Belgium

    Andreas Otte

Authors
  1. Stefan M. Weiner
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Andreas Otte
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Division of Nuclear Medicine, University Hospital Ghent, De Pintelaan 185, 9000, Gent, Belgium

    Andreas Otte  & Rudi A. Dierckx  & 

  2. University Department of Psychiatry, University Hospital Ghent, De Pintelaan 185, 9000, Gent, Belgium

    Kurt Audenaert  & Kees van Heeringen  & 

  3. Department of Medical Imaging Faculty of Veterinary Medicine, Ghent University, Salisburylaan 133, 9820, Merelbeke, Belgium

    Kathelijne Peremans

Rights and permissions

Reprints and permissions

Copyright information

© 2004 Springer-Verlag Berlin Heidelberg

About this chapter

Cite this chapter

Weiner, S.M., Otte, A. (2004). Neuropsychiatric Involvement in Systemic Lupus Erythematosus. In: Otte, A., Audenaert, K., Peremans, K., van Heeringen, K., Dierckx, R.A. (eds) Nuclear Medicine in Psychiatry. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-18773-5_15

Download citation

  • DOI: https://doi.org/10.1007/978-3-642-18773-5_15

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-642-62287-8

  • Online ISBN: 978-3-642-18773-5

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation